Evidence map›Paper›PMID 34630104›Full record

ArticleFrontiers in pharmacology2021

Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence.

Ping Zheng, Ze Yu, Liren Li, Shiting Liu, Yan Lou, Xin Hao, Peng Yu, Ming Lei, Qiaona Qi, Zeyuan Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Prevalence and factors associated with potentially inappropriate medications in elderly stroke patients: A comparison of Beers 2019 and 2023 criteria.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Interpretable Machine Learning Models for Predicting Malignant Ventricular Arrhythmia in Patients with Acute ST-Segment Elevation Myocardial Infarction Based on Systemic Inflammation Index.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
  19. Machine Learning to Dynamically Predict In-Hospital Venous Thromboembolism After Inguinal Hernia Surgery: Results From the CHAT-1 Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ping ZhengDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ze YuBeijing Medicinovo Technology Co. Ltd., Beijing, China.
Liren LiDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shiting LiuDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yan LouDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xin HaoDalian Medicinovo Technology Co. Ltd., Dalian, China.
Peng YuBeijing Medicinovo Technology Co. Ltd., Beijing, China.
Ming LeiDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qiaona QiBeijing Medicinovo Technology Co. Ltd., Beijing, China.
Zeyuan WangBeijing Medicinovo Technology Co. Ltd., Beijing, China.
Fei GaoBeijing Medicinovo Technology Co. Ltd., Beijing, China.
Yuqing ZhangZhongshan School of Medicine, SYSU, Guangzhou, China.
Yilei LiDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Southern Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tacrolimus is a widely used immunosuppressive drug in patients with autoimmune diseases. It has a narrow therapeutic window, thus requiring therapeutic drug monitoring (TDM) to guide the clinical regimen. This study included 193 cases of tacrolimus TDM data in patients with autoimmune diseases at Southern Medical University Nanfang Hospital from June 7, 2018, to December 31, 2020. The study identified nine important variables for tacrolimus concentration using sequential forward selection, including height, tacrolimus daily dose, other immunosuppressants, low-density lipoprotein cholesterol, mean corpuscular volume, mean corpuscular hemoglobin, white blood cell count, direct bilirubin, and hematocrit. The prediction abilities of 14 models based on regression analysis or machine learning algorithms were compared. Ultimately, a prediction model of tacrolimus concentration was established through eXtreme Gradient Boosting (XGBoost) algorithm with the best predictive ability (

Indexed as

autoimmune diseaseblood concentration predictionmachine learningtacrolimustherapeutic drug monitoring

Identifiers

PMID34630104
PMCPMC8497784
OpenAlexW3204536821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.